[go: up one dir, main page]

MA39000A1 - Compositions et méthodes permettant d'inhiber l'expression du gène alas1 - Google Patents

Compositions et méthodes permettant d'inhiber l'expression du gène alas1

Info

Publication number
MA39000A1
MA39000A1 MA39000A MA39000A MA39000A1 MA 39000 A1 MA39000 A1 MA 39000A1 MA 39000 A MA39000 A MA 39000A MA 39000 A MA39000 A MA 39000A MA 39000 A1 MA39000 A1 MA 39000A1
Authority
MA
Morocco
Prior art keywords
compositions
methods
alas1 gene
gene expression
inhibiting alas1
Prior art date
Application number
MA39000A
Other languages
English (en)
Other versions
MA39000B1 (fr
Inventor
Brian Bettencourt
Kevin Fitzgerald
William Querbes
Robert Desnick
Makiko Yasuda
Original Assignee
Alnylam Pharmaceuticals Inc
Icahn School Med Mount Sinai
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alnylam Pharmaceuticals Inc, Icahn School Med Mount Sinai filed Critical Alnylam Pharmaceuticals Inc
Priority claimed from PCT/US2014/059160 external-priority patent/WO2015051318A1/fr
Publication of MA39000A1 publication Critical patent/MA39000A1/fr
Publication of MA39000B1 publication Critical patent/MA39000B1/fr

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

La présente invention concerne des compositions d'acide ribonucléique double brin (arndb) ciblant le gène alas1, ainsi que des méthodes d'utilisation desdites compositions d'arndb pour altérer (par exemple, inhiber) l'expression du gène alas1.
MA39000A 2013-10-04 2014-10-03 Compositions et méthodes permettant d'inhiber l'expression du gène alas1 MA39000B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361887288P 2013-10-04 2013-10-04
PCT/US2014/059160 WO2015051318A1 (fr) 2013-10-04 2014-10-03 Compositions et méthodes permettant d'inhiber l'expression du gène alas1

Publications (2)

Publication Number Publication Date
MA39000A1 true MA39000A1 (fr) 2018-05-31
MA39000B1 MA39000B1 (fr) 2018-12-31

Family

ID=58698725

Family Applications (1)

Application Number Title Priority Date Filing Date
MA39000A MA39000B1 (fr) 2013-10-04 2014-10-03 Compositions et méthodes permettant d'inhiber l'expression du gène alas1

Country Status (2)

Country Link
AR (2) AR097920A1 (fr)
MA (1) MA39000B1 (fr)

Also Published As

Publication number Publication date
AR118658A2 (es) 2021-10-20
MA39000B1 (fr) 2018-12-31
AR097920A1 (es) 2016-04-20

Similar Documents

Publication Publication Date Title
ZA202002019B (en) Serpinc1 irna compositions and methods of use thereof
WO2013155204A3 (fr) Compositions et procédés permettant d'inhiber l'expression du gène alas1
MX2018013216A (es) Composiciones y metodos para inhibir la expresion del gen de proteasa transmembrana, serina 6 (tmprss6).
MX418589B (es) Composiciones de arni contra el componente c5 del complemento y metodos para su uso.
EA202092987A3 (ru) Липид, содержащий докозапентаеновую кислоту
JO3558B1 (ar) تركيبات وطرق لتثبيط التعبير الجيني عن hao1 (حمض أوكسيداز هيدروكسيلي 1 (أوكسيداز جليكولات))
MX2021015290A (es) Composiciones y metodos para inhibicion de genes para apolipoproteina c-iii (apoc3).
PH12016500574A1 (en) Compositions and methods for inhibiting expression of the alas1 gene
MA37571A1 (fr) Compositions pesticides et procédés correspondants
MA38686A1 (fr) Anticorps anti-acide téichoïque de la paroi cellulaire et conjugués associés
EP2576536A4 (fr) Inhibiteurs de la prostaglandine d2 synthase hématopoïétique
MX385871B (es) Composiciones y metodos para inhibir la expresion del gen lect2.
EA201590268A1 (ru) Ариллактамные ингибиторы киназы
MA39170A1 (fr) Composes inhibiteurs de sérine/thréonine kinase pour leurs utilisations dans le traitement du cancer
MA39000B1 (fr) Compositions et méthodes permettant d'inhiber l'expression du gène alas1
IN2015DN02699A (fr)
EA201591444A1 (ru) Мутированные гены алленоксидсинтазы 2 (aos2)
MA38931A1 (fr) Utilisation de l'odiparcil dans le traitement d'une mucopolysaccharidose
MY185464A (en) Complement component c5 irna compositions and methods of use thereof
AR094594A1 (es) Cebada resistente a herbicidas
TW202605150A (zh) ＴＭＰＲＳＳ６ ｉＲＮＡ組成物及其使用方法
EA202091923A1 (ru) Замещенные трициклические соединения как ингибиторы fgfr
EA037110B9 (ru) КОМПОЗИЦИИ С иРНК К PCSK9 И СПОСОБЫ ИХ ПРИМЕНЕНИЯ